The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000727347p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
11/05/2026
Date registered
Help: Date registered
17/06/2026
Date last updated
Help: Date last updated
17/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
17/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Adding cognitive behavioural therapy for insomnia to usual physiotherapy care for chronic low back pain and osteoarthritis of hip and knee: the SLEEP-MSK randomised controlled trial
Scientific title
The effect of adding cognitive behavioural therapy for insomnia to usual care for chronic musculoskeletal conditions: protocol for an adaptive basket randomised controlled trial (SLEEP-MSK)
Additional trial identifiers [1] 317245 0
MRF2040668 (MRFF funding number)
Universal Trial Number (UTN)
Trial acronym
SLEEP-MSK
Related trial records

Health condition
Health condition(s) studied:
Chronic low back pain 341857 0
Hip osteoarthritis 341858 0
Knee osteoarthritis 341859 0
Insomnia 341860 0
Condition category
Condition code
Musculoskeletal 337926 337926 0 0
Osteoarthritis
Musculoskeletal 337927 337927 0 0
Other muscular and skeletal disorders
Physical Medicine / Rehabilitation 338250 338250 0 0
Physiotherapy

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Participants allocated to the cognitive behavioural therapy for insomnia (CBT-I) and usual care group will receive usual care as described above in addition to a structured physiotherapist-delivered CBT-I intervention. Usual care is led by a physiotherapist and may include education, self-management advice, exercise therapy and physical activity recommendations.

This is a basket trial involving participants with knee osteoarthritis, hip osteoarthritis and low back pain. Participants across all musculoskeletal conditions will receive the same CBT-I intervention. The same primary and secondary outcomes will be assessed across all conditions.

Participants commence the trial on the day of their first usual care appointment with their physiotherapist. They will be randomised by the study team and if randomised to the CBT-I group, they will have a CBT-I appointment scheduled. Participants will receive 6 CBT-I appointments (~30 mins each session) over a period of 8 weeks. The CBT-I appointments do not need to be scheduled at the same time as their usual care appointments. Most CBT-I appointments will be delivered over the phone or online, but can be delivered in-person if needed due to convenience.

Physiotherapists will receive up to 4 hours of training in CBT-I delivered online via a bespoke eLearning program based on recordings slides and educational materials developed previously for in-person training delivered by Prof Sue McCurry (University of Washington, Clinical Psychologist). The eLearning modules will be supplemented by voice-to-voice AI patient avatars developed on case studies from real study participants developed with the support of the University of Sydney Faculty of Medicine and Health Media Lab. The AI avatars will provide physiotherapists with an opportunity for real-time practice in delivering the six sessions of CBT-I using their new knowledge and skills, and increase their familiarity with using the physiotherapist treatment notes to structure the sessions.

The intervention includes behavioural, cognitive, circadian rhythm, and educational strategies for insomnia management.

Behavioural strategies: (1) Stimulus control: Strengthens bed and bedroom as sleep stimuli. Interventions may include adjusting sleep timing, managing light exposure, and reinforcing consistent wake times to support optimal sleep regulation. (2) Sleep (Bed) restriction: Restricts time in bed to improve sleep depth and consolidation. Participants are prescribed a personalised sleep plan using a daily electronic sleep diary. Their time in bed is adjusted as their sleep efficiency (% time spent asleep/total time in bed) changes over time. The aim is to achieve sleep efficiency of 85% or better. (3) Sleep hygiene: Promotes habits and environments that help sleep.

Cognitive strategies: (1) Cognitive therapy: Addresses unhelpful beliefs, worries, and expectations that interfere with sleep. Interventions may include cognitive restructuring, constructive worry, and mindfulness practices. (2) Relaxation/mindfulness training: Reduces arousal and decrease anxiety. (3) Acceptance based: Decrease struggle to control sleep at cost of living your life.

The circadian component targets the timing of sleep and wake cycles, helping align sleep patterns with natural biological rhythms. Interventions may include adjusting sleep timing, managing light exposure, and reinforcing consistent wake times to support optimal sleep regulation.

Education: Core education about insomnia – understanding what insomnia is, how it develops, and why it often persists over time. Participants are educated about the 3P (+1) model of insomnia – understanding Predisposing, Precipitating, and Perpetuating factors, plus Protective factors, that influence sleep difficulties. CBT-I equips people with tools to manage their sleep independently, promoting long-term success and resilience. It empowers people to track their own progress and adapt strategies that enhance their confidence and engagement in the recovery process.

Participants will complete daily sleep diaries, and this information will be used to tailor behavioural prescriptions and sleep scheduling recommendations. Examples, include recommendations regarding bedtime, wake time, and avoidance of daytime napping.

Minor modifications to CBT-I delivery will be permitted to enhance feasibility and participant-centred care, including adjustments to session length, mode of delivery and pacing of behavioural prescriptions. Intervention fidelity will be assessed using structured clinician checklists and audit of audio-recorded sessions (with participant consent). Attendance at intervention sessions will be recorded by physiotherapists in REDCap.

Intervention code [1] 334018 0
Treatment: Other
Description of the comparator or control
The comparator group will receive usual outpatient physiotherapy care for up to 6 months through participating Australian health services. Usual care will be delivered by registered physiotherapists according to each participating health provider’s existing services and capacity. Typically, usual care involves management over several visits focused on lifestyle management including education for self-management, advice, exercise and physical activity.

Consultations may be delivered individually either face-to-face within outpatient physiotherapy departments or via telehealth according to routine clinical practice and participant needs. The frequency, duration and total number of consultations will be pragmatic and determined by the treating physiotherapist according to participant presentation and usual care pathways. Attendance at consultations will be recorded by physiotherapists in REDCap.
Control group
Active

Outcomes
Primary outcome [1] 345369 0
Average overall pain severity in the last week
Timepoint [1] 345369 0
Measured at baseline and at 2, 6 and 12 months post randomisation, with the primary timepoint being 6 months.
Primary outcome [2] 345370 0
Insomnia severity
Timepoint [2] 345370 0
Measured at baseline and at 2, 6 and 12 months post randomisation, with the primary timepoint being 6 months.
Secondary outcome [1] 461442 0
Pain interference
Timepoint [1] 461442 0
Measured at baseline and at 2, 6 and 12 months post randomisation.
Secondary outcome [2] 461443 0
Sleep disturbance
Timepoint [2] 461443 0
Measured at baseline and at 2, 6 and 12 months post randomisation.
Secondary outcome [3] 461444 0
Sleep-related impairment
Timepoint [3] 461444 0
Measured at baseline and at 2, 6 and 12 months post randomisation.
Secondary outcome [4] 461445 0
Physical function
Timepoint [4] 461445 0
Measured at baseline, 2 months, 6 months and 12 months.
Secondary outcome [5] 461446 0
Health-related quality of life
Timepoint [5] 461446 0
Measured at baseline and at 2, 6 and 12 months post randomisation.
Secondary outcome [6] 461447 0
Pain self-efficacy
Timepoint [6] 461447 0
Measured at baseline and at 2, 6 and 12 months post randomisation.
Secondary outcome [7] 461448 0
Global rating of change in overall health
Timepoint [7] 461448 0
Measured at 2 months, 6 months and 12 months post randomisation.
Secondary outcome [8] 461449 0
Participant satisfaction with treatment
Timepoint [8] 461449 0
Measured at 2 months, 6 months and 12 months post randomisation.

Eligibility
Key inclusion criteria
1. Referred to a participating hospital-based outpatient physiotherapy service for management of chronic low back pain and/or osteoarthritis of the hip or knee.
2. Aged 18 years or older and low back pain defined as moderate pain-related interference with normal work or daily activity by item 8 of the 36-item Short Form Health Survey and/or osteoarthritis of the hip or knee according to the National Institute for Health and Care Excellence clinical criteria (aged 45 years or older, activity-related hip and/or knee pain, and morning stiffness lasting 30 minutes or less).
3. Low back, hip or knee pain on most days for at least 3 months.
4. Average low back, hip or knee pain over the last week of 4 or greater on an 11-point numerical rating scale where 0 = “No pain” and 10 = “Worst pain possible”.
5. Insomnia Severity Index score of 11 or greater.
6. Meets Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for insomnia disorder.
7. Has access to a smartphone or device with internet access.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
1. Current or previous participation in cognitive behavioural therapy for insomnia (CBT-I) within the past 6 months.
2. Regular overnight shift workers (i.e. shifts occurring between 12am and 6am).
3. Cognitive impairment defined as a score of 7 or greater on the Short Orientation Memory Concentration Test.
4. Women who are pregnant, lactating, or of childbearing potential who are unwilling to avoid pregnancy during the study.
5. Sciatica, spinal stenosis, spinal fracture, systemic inflammatory disease or cancer.
6. Received an injection (e.g. cortisone, platelet-rich plasma or viscosupplementation) into the primary affected area (lower back, hip or knee) within the previous 3 months.
7. Waiting for or planning to receive an injection into the primary affected area within the next 12 months.
8. Surgery for low back, hip or knee pain within the previous 12 months, or planned surgery within the next 12 months.
9. History of a psychological illness or condition likely to interfere with the participant’s ability to understand study requirements.
10. History of a clinically relevant medical, behavioural or psychiatric disorder, other than obstructive sleep apnoea, associated with insomnia or excessive sleepiness.
11. Unable to provide informed consent or participate in the intervention or assessment procedures.
12. Unable to speak or read English.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
To conceal allocation, the randomisation schedule will be embedded within the REDCap randomisation module and accessed only after confirmation of participant eligibility, informed consent and completion of baseline assessments. The person determining whether a participant is eligible for inclusion in the trial will be unaware, when this decision is made, to which group the participant will be allocated. The computer-generated allocation schedule will be prepared by an independent statistician not involved in recruitment, screening, assessment or intervention delivery.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
The randomisation schedule will be computer generated by an independent statistician using random permuted blocks of varying sizes. Participants will be randomised on a 1:1 basis to either usual care alone or cognitive behavioural therapy for insomnia (CBT-I) and usual care. Randomisation will be stratified by state (NSW, QLD, WA) and sex (female, male)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Analyses will be conducted using the intention-to-treat principle. Continuous outcomes will be analysed using linear mixed-effects models adjusted for baseline values, treatment group and time. Binary outcomes will be analysed using generalised mixed-effects models. Sensitivity and moderator analyses will also be performed.

The trial incorporates a two-stage adaptive basket design with a planned interim futility analysis. Secondary Bayesian analyses will explore borrowing of information across musculoskeletal conditions where appropriate.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD,WA
Recruitment hospital [1] 29499 0
Royal North Shore Hospital - St Leonards
Recruitment hospital [2] 29500 0
Westmead Hospital - Westmead
Recruitment hospital [3] 29502 0
Hornsby Ku-ring-gai Hospital - Hornsby
Recruitment hospital [4] 29503 0
Royal Perth Hospital - Perth
Recruitment hospital [5] 29504 0
Princess Alexandra Hospital - Woolloongabba
Recruitment hospital [6] 29505 0
Queen Elizabeth II Jubilee Hospital - Coopers Plains
Recruitment hospital [7] 29506 0
Royal Brisbane & Womens Hospital - Herston
Recruitment hospital [8] 29507 0
The Prince Charles Hospital - Chermside
Recruitment hospital [9] 29508 0
Bentley Health Service - Bentley
Recruitment postcode(s) [1] 45817 0
2065 - St Leonards
Recruitment postcode(s) [2] 45818 0
2145 - Westmead
Recruitment postcode(s) [3] 45820 0
2077 - Hornsby
Recruitment postcode(s) [4] 45821 0
6000 - Perth
Recruitment postcode(s) [5] 45822 0
4102 - Woolloongabba
Recruitment postcode(s) [6] 45823 0
4108 - Coopers Plains
Recruitment postcode(s) [7] 45824 0
4029 - Herston
Recruitment postcode(s) [8] 45825 0
4032 - Chermside
Recruitment postcode(s) [9] 45826 0
6102 - Bentley

Funding & Sponsors
Funding source category [1] 321819 0
Government body
Name [1] 321819 0
Australian Government Department of Health, Disability and Ageing – Medical Research Future Fund (MRFF)
Country [1] 321819 0
Australia
Primary sponsor type
University
Name
The University of Sydney
Address
Country
Australia
Secondary sponsor category [1] 324671 0
None
Name [1] 324671 0
Address [1] 324671 0
Country [1] 324671 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320362 0
Northern Sydney Local Health District Human Research Ethics Committee
Ethics committee address [1] 320362 0
Ethics committee country [1] 320362 0
Australia
Date submitted for ethics approval [1] 320362 0
24/10/2025
Approval date [1] 320362 0
Ethics approval number [1] 320362 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150226 0
A/Prof Michelle Hall
Address 150226 0
Level 7 Susan Wakil Health Building, D18 Western Avenue The University of Sydney Camperdown, NSW 2050
Country 150226 0
Australia
Phone 150226 0
+61 4 32128223
Fax 150226 0
Email 150226 0
Contact person for public queries
Name 150227 0
Michelle Hall
Address 150227 0
Level 7 Susan Wakil Health Building, D18 Western Avenue The University of Sydney Camperdown, NSW 2050
Country 150227 0
Australia
Phone 150227 0
+61 4 32128223
Fax 150227 0
Email 150227 0
Contact person for scientific queries
Name 150228 0
Michelle Hall
Address 150228 0
Level 7 Susan Wakil Health Building, D18 Western Avenue The University of Sydney Camperdown, NSW 2050
Country 150228 0
Australia
Phone 150228 0
+61 4 32128223
Fax 150228 0
Email 150228 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• De-identified individual participant data:
• All outcomes data
• Primary outcome(s)
• Safety data
What types of analyses could be done with individual participant data?
• Systematic reviews and meta-analyses
• Studies exploring new research questions
• Health economic analyses
• Studies testing whether findings can be repeated or confirmed
• Teaching research methods or developing new statistical techniques
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
Yes: Access to de-identified participant data will be considered on a case-by-case basis following publication of the main study results. Requests must include a scientifically sound proposal and may require a data sharing agreement with the study investigators and sponsor. Data sharing will be subject to applicable ethics approvals, institutional policies and participant confidentiality requirements.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.